ALXO vs CDNS · $207.2M cap vs P/E 82, rev $5.30B
Alx Oncology Holdings (ALXO) versus Cadence Design Systems Inc (CDNS) — a side-by-side from cached financials, not a winner call.
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US. It is led by Anirudh Devgan Ph.D..
ALXO does not have a complete income-statement cache yet.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
ALXO currently screens at market cap $207.2M. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Not investment advice. Open the ALXO and CDNS stock pages for the full models.
Not investment advice.